Therapeutically targeting head and neck squamous cell carcinoma through synergistic inhibition of LSD1 and JMJD3 by TCP and GSK-J1.
Wei ZhangJie ChengPengfei DiaoDongmiao WangWei ZhangHongbing JiangYanling WangPublished in: British journal of cancer (2019)
Our findings revealed a novel therapeutic strategy of simultaneous LSD1 and JMJD3 inhibition against HNSCC.